Skip to NavigationSkip to content

Pharmafile - Manufacturing and Production

Giliad's Yesarta becomes second FDA-approved CAR T treatment and AstraZeneca admits efficacy data for an acquired cancer drug was fabricated. Check...
Novartis has announced its intention to shut down its US generics manufacturing plant in Broomfield, Colorado, a move that will lead to a loss of...
AstraZeneca and partner Hutchison China MedTech have announced positive data for savolitinib in combination with either AstraZeneca’s Tagrisso or...
Aimmune Therapeutics, a biotech company developing treatments for food allergies, announced that it has entered into a clinical trial collaboration...

Features

Peter Naredi, of ECCO, explores how a multi-dimensional approach is necessary to ensure that patients receive access to the most important medical...

Appointments

NHS Scotland has revealed the appointment of Professor David Crossman as its new Chief Scientist, after advertising externally to fill the...

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches